Provided by Tiger Fintech (Singapore) Pte. Ltd.

Day One Biopharmaceuticals Inc.

6.97
-0.2300-3.19%
Post-market: 6.970.00000.00%16:20 EDT
Volume:879.10K
Turnover:6.16M
Market Cap:713.95M
PE:-7.43
High:7.19
Open:7.16
Low:6.94
Close:7.20
52wk High:16.76
52wk Low:5.64
Shares:102.43M
Float Shares:78.77M
Volume Ratio:0.65
T/O Rate:1.12%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9382
EPS(LYR):-1.0243
ROE:-24.75%
ROA:-15.19%
PB:1.55
PE(LYR):-6.80

Loading ...

Day One Biopharmaceuticals (DAWN) Gets a Buy from Goldman Sachs

TIPRANKS
·
Jul 16

Day One Biopharmaceuticals Files Initial Ownership Statement; Michael Vasconcelles Named as Head of Research and Development

Reuters
·
Jun 19

Day One Biopharmaceuticals Inc. Appoints Michael Vasconcelles, M.D., as Head of Research and Development to Lead Pipeline Growth

Reuters
·
Jun 10

Day One Biopharmaceuticals Inc. Conducted Annual Stockholders Meeting

Reuters
·
Jun 04

Chief Commercial Officer Lauren Merendino Reports Disposal of Common Shares in Day One Biopharmaceuticals Inc

Reuters
·
May 20

Adam Dubow, General Counsel, Reports Disposal of Day One Biopharmaceuticals Inc. Common Shares

Reuters
·
May 20

York Charles N II, COO, CFO and Secretary, Reports Disposal of Common Shares of Day One Biopharmaceuticals Inc

Reuters
·
May 20

Stock Track | Day One Biopharmaceuticals Soars 7.58% as Needham Reaffirms Buy Rating Despite Seasonal Challenges

Stock Track
·
May 07

Stock Track | Day One Biopharmaceuticals Soars 5.29% Pre-market as Needham Reaffirms Buy Rating

Stock Track
·
May 07

Positive Outlook for Day One Biopharmaceuticals Despite Seasonal Challenges, Buy Rating Reaffirmed

TIPRANKS
·
May 07

Day One Biopharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 07

Day One Biopharmaceutical Q1 EPS $(0.35) Beats $(0.44) Estimate, Sales $30.76M Beat $30.24M Estimate

Benzinga
·
May 07

BRIEF-Day One Biopharmaceuticals Q1 EPS USD -0.35 Vs. IBES Estimate USD -0.44

Reuters
·
May 07

Q1 2025 American International Group Inc Earnings Call

Thomson Reuters StreetEvents
·
May 03

Day One to Report First Quarter 2025 Financial Results Tuesday, May 6, 2025

GlobeNewswire
·
Apr 22

BofA Adjusts Price Target on Day One Biopharmaceuticals to $21 From $24, Keeps Buy Rating

MT Newswires Live
·
Apr 17

Day One Biopharmaceuticals price target lowered to $21 from $24 at BofA

TIPRANKS
·
Apr 17

Bank of America Securities Sticks to Their Buy Rating for Day One Biopharmaceuticals (DAWN)

TIPRANKS
·
Apr 17

UNDER ARMOUR APPOINTS DAWN N. FITZPATRICK, EUGENE D. SMITH, AND ROBERT J. SWEENEY TO ITS BOARD OF DIRECTORS

PR Newswire
·
Apr 15

Day One Biopharm Price Target Maintained With a $36.00/Share by HC Wainwright & Co.

Dow Jones
·
Apr 03